In 2021, Radhika Iyer et al. corroborated that Entrectinib elevated the expression of E-cadherin, a protein extensively expressed in epithelial cells, at both mRNA and protein levels in gastric cancer cells (Sohn et al. 2021). Here, CDH1 is linked to gastric cancer.